Mechanistic insights of lenvatinib: enhancing cisplatin sensitivity, inducing apoptosis, and suppressing metastasis in bladder cancer cells through EGFR/ERK/P38/NF-κB signaling inactivation

Table 4 Mean tumor growth time, delay time and inhibition rate in MB49 tumor-bearing mice after treatment with different doses of lenvatinib

na: not available
^*Mean tumor growth time (MTGT): the time at which the MB49 tumor volume reached 500 mm³. ^#Mean tumor growth delay time (MTGDT): the mean MB49 tumor growth time of the treated group minus that of the control group (0 mg/kg lenvatinib, 0.1% DMSO, CTRL). ^$Mean growth inhibition rate (MGIR): the mean MB49 tumor growth time of the lenvatinib-treated group/the mean MB49 tumor growth time of the control group

ISSN: 1475-2867